Cardio Diagnostics Holdings

Cardio Diagnostics is a publicly traded precision cardiovascular medicine company focused on blood-based cardiovascular diagnostic testing. The company combines epigenetics, genetics, and artificial intelligence to develop and commercialize clinical tests intended to improve coronary heart disease risk assessment and detection. Its flagship commercial products include Epi+Gen CHD, a blood test for symptomatic coronary heart disease risk assessment, and PrecisionCHD, a blood test for detection and management of coronary heart disease. Cardio Diagnostics also offers software and research solutions such as Actionable Clinical Intelligence, HeartRisk, and CardioInnovate360, and has pursued reimbursement expansion and international commercialization partnerships, including in India. The company is headquartered in Chicago and operates through Cardio Diagnostics Holdings, Inc. and its wholly owned subsidiary, Cardio Diagnostics, Inc.